Introduction: Chronic suppurative otitis media (CSOM) is a chronic inflammation of the middle ear and mastoid cavity, which presents with recurrent ear discharge through a tympanic perforation. The WHO has classified India as a country with highest prevalence ( > 4%) requiring urgent attention to deal with a massive public health problem. CSOM is often associated with a bone eroding process which occurs due to the presence of cholesteotoma, granulation tissue or both. Methods: This study was conducted in a department of E.N.T, Yenepoya Medical College Hospital, Deralakatte, Mangalore for a period of 2 years. This study was conducted to evaluate the ossicular involvement in chronic suppurative otitis media (CSOM). A retrospective-prospective study was conducted over a 2-year period on 86 patients who underwent surgery for the disease. Demography, ossicular status and hearing loss were studied and analyzed using SPSS programme. Results: The study revealed Tubotympanic disease was the more common type of disease. Ossicular necrosis was present in 35% of population. The most common ossicles involved were the whole of incus, followed by lenticular process and long process of incus. There was a higher incidence of ossicular disruption in atticoantral disease than in tubotympanic disease.
Enbloc heart and lung transplantation is the recommended ultimate option of surgery for candidates suffering from irreversible end stage heart and lung disease. This major surgery requires a cohesive multidisciplinary teamwork approach to yield a favourable outcome. The role of perfusionist is vital in this complex operation who is an active participant in the preoperative period intra-op and post-operative period. Our Enbloc heart and lung experience - case report highlights the key elements of this surgery from the perfusionist perspective. A 68 year old male patient was suffering from end stage heart and lung disease refractory to medical therapy due to worsened interstitial lung disease and coronary artery disease. His life style was restricted and required heart and lung transplantation at the earliest. He got a suitable donor and successfully underwent Enbloc heart and lung transplantation. The donor was a 24 year old male who was in comatose state due to traumatic brain injury. The donor specific antibody test was performed and the report was negative. Cold custodial and Perfadex Plus was administered to the donor heart and lungs and were harvested. The gold standard approach for Enbloc heart and lung transplantation is the median sternotomy. Standard bicaval and aortic cannulation was done and cardiopulmonary bypass was instituted. The total Cardio Pulmonary Bypass time was 250 minutes. Cold cycle was 144 minutes and warm cycle was 75 minutes. Continuous zero balanced ultrafiltration was done to eliminate the inflammatory mediators and to keep the serum lactate within the normal limits. The various perfusion strategies involved in Enbloc heart and lung transplantation and the involvement of perfusionists in the management of these patients is discussed in the article. Enbloc heart and lung transplantation is the treatment of choice for end-stage heart and lung disease. This type of surgery demands a holistic teamwork approach involving a multidisciplinary team and this helped in the speedy recovery of the patient in the case presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.